Spear Therapeutics Raise $8.5 Million To Fund Cancer Drug Development

November 28, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Cancer Research Technology (CRT), Bloomsbury Bioseed Fund (BBSF), De Montfort University (DMU) and the Gray Cancer Institute announce today that U.S. venture capital firm Advent International has invested $8.5 million in Spear Therapeutics Ltd.

Twitter
LinkedIn
Facebook
Email
Print

Startups Europe